News & Events

Primary tabs

Fateful evolution: new study improves accuracy of cancer diagnosis

August 24, 2016

A disorder known as Barrett’s esophagus (BE) affects some 200,000 Americans each year. The condition, which is caused by stomach acid damaging the lining of the esophagus, can lead to the development of a serious, potentially fatal cancer of epithelial tissue, known as esophageal adenocarcinoma (EAC). In a new study, Carlo Maley, a researcher at Arizona State University’s Biodesign Institute, uses evolutionary theory to make predictions about which BE patients will go on to develop...

The power of the patch: New project aims to make innovative device to empower consumer health

August 22, 2016

Karen Anderson is an ASU scientist who sees firsthand patient’s struggles with cancer while making rounds as a Mayo Clinic oncologist. Jennifer Blain Christen is an ASU electrical engineer who is pushing the boundaries of sensors and circuits technology to improve health care. Together, the ASU dynamic duo has combined their expertise to make a difference for people to quickly and inexpensively check their health status. Anderson, M.D., Ph.D., of the Virginia G. Piper Center for...

Fostering North American partnerships

August 16, 2016

Sethuraman "Panch" Panchanathan (left), senior vice president for ASU's Knowledge Enterprise Development; Joshua LaBaer, an executive with the Biodesign Institute; and Luis Armando Kuroda of Mexico's Salud Digna and Fundación Vizcarra (right) sign a memorandum of understanding (MOU) on Aug. 15. The MOU establishes a commitment to collaborate using ASU's undergraduate and graduate scientific researchers and Salud Digna's preventative health-care services with the goal of bringing greater...

LaBaer advances disease research, claims important award

July 15, 2016

Josh LaBaer, M.D., PhD., a leading researcher in the rapidly expanding field of proteomics, has just been awarded the 2016 Translational Proteomics Award from the Human Proteome Organization (or HUPO). The prestigious award recognizes professor LaBaer’s distinguished scientific achievements in the field of translational proteomics science. HUPO is an international scientific organization promoting proteomics through international cooperation and collaboration, fostering the development of...

From worms to cancer cures

July 5, 2016

The path from roundworm genes to curing cancer isn’t an easy one. But a handful of students and faculty at Arizona State University are joining forces to increase our understanding of how small biological changes in genes can influence the development, diagnosis and treatment of cancer. Two faculty laboratories within ASU’s Virginia G. Piper Center for Personalized Diagnostics — and the students who work there — are fusing fundamental science with clinical research to create more...

Mathematical and Computational Models of Cancer and The Immune System

June 30, 2016

Diego Chowell, Graduate Research Assistant, Biodesign Institute Virginia G. Piper Center for Personalized Diagnostics The immune system plays a dual role during neoplastic progression. It can suppress tumor growth by eliminating cancer cells, and also promote neoplastic expansion by either selecting for tumor cells that are fitter to survive in an immunocompetent host or by establishing the right conditions within the tumor microenvironment.  This is a dissertation defense, hosted by...

ASU reaches next milestone in multi-million dollar program to develop an automated, high-throughput diagnostic test for estimating absorbed radiation

June 15, 2016

Arizona State University’s Biodesign Institute announced today it is entering a new, $7M phase of a multi-million, multi-institutional development project to produce a diagnostic test to measure an individual’s level of absorbed radiation in the event of an unplanned radiological or nuclear event. Currently, there is no U.S. Food and Drug Administration cleared or approved, high-throughput system to measure the radiation dose absorbed by individuals within a large population. The ASU...

Biomedicine and Biotechnology

April 13, 2016

Stephen Johnston, Ph.D., Professor and Co-director, Biodesign Center for Innovations in Medicine; Hugh Mason, Ph.D., Associate Professor, Biodesign Center for Infectious Diseases and Vaccinology; and Carlo Maley, Ph.D., Associate Professor, Virginia G. Piper Biodesign Center for Personalized Diagnostics. The ASU School of Life Sciences is presenting this seminar.  

International collaboration reaches milestone in curating new resource for unraveling human disease

February 25, 2016

Gene bank collection now totals 80 percent of all human protein-coding genes, collaboration reports An international collaboration of organizations, including Arizona State University’s Biodesign Institute and the Dana-Farber Cancer Institute, has reached a milestone in creating a library of complete genetic blueprints for the thousands of different proteins in human cells, called the human proteome. The collection – consisting of open-reading frames (ORFs), the portions of genes that...

BioPolicy Summit tackles reproducibility of science issues

February 11, 2016

To err is human, even for one of the most number crunching, rigorous and truth seeking of all activities: science. The issue of errors in science --- irreproducible research --- was recently a focal point for a national discussion when the Global Biological Standards Institute (GBSI) hosted its 2016 BioPolicy Summit. The 2016 GBSI Summit—“Research Reproducibility: Innovative Solutions to Drive Quality” welcomed premiere life science thought leaders, including Arizona State University...